Vascular - SSB 11-02

Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta

Dr. Davinigracia in conjunction with the vascular surgical group will be participating in this trial.  The primary objective of the study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis (TBE device) is safe and effective in treating thoracic aortic pathologies. This will be a non-randomized, multicenter, prospective study conducted at up to forty (40) Clinical Investigative Sites in the U.S with the objective of determining whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta.

ELIGIBILITY CRITERIA:

  • Presence of thoracic aortic pathology warranting surgical repair with proximal graft placement

Please contact Alison Champagne at 860-972-6049 or email at Alison.champagne@hhchealth.org